Walgreens Boots Alliance Crecimiento futuro

Future controles de criterios 3/6

Se prevé un crecimiento anual de los beneficios y los ingresos de Walgreens Boots Alliance de 68.4% y 3.7% por año respectivamente. Se prevé que el BPA crezca en un 73.5% al año. Se espera que la rentabilidad financiera sea de 19.4% en 3 años.

Información clave

68.4%

Tasa de crecimiento de los beneficios

71.3%

Tasa de crecimiento del BPA

Crecimiento de los beneficios de Consumer Retailing	11.5%
Tasa de crecimiento de los ingresos	3.7%
Rentabilidad financiera futura	19.4%
Cobertura de analistas	Good
Última actualización	26 Apr 2024

Actualizaciones recientes sobre el crecimiento futuro

Recent updates

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Apr 10

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Apr 08

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

Apr 04

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Mar 27

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

Dec 24

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Oct 31

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Oct 02

Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48

Aug 01

Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48

Jul 16

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Jul 04

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Apr 25

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Mar 08

Walgreens Boots Alliance (NASDAQ:WBA) Has Affirmed Its Dividend Of $0.48

Feb 01

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Nov 01

Walgreens Boots Alliance Dividend is Solid, but it Might Not be Enough

Oct 16

Walgreens Boots Alliance - A Company In Transition

Oct 14

6%-Yielding Walgreens Is Now Ridiculously Cheap

Oct 08

Previsiones de crecimiento de beneficios e ingresos

NasdaqGS:WBA - Estimaciones futuras de los analistas y datos financieros pasados (USD Millions)
Fecha	Ingresos	Beneficios	Flujo de caja libre	Flujo de caja operativo	Núm. de analistas medio
8/31/2026	157,307	2,243	2,704	4,437	11
8/31/2025	150,911	1,955	2,285	4,036	17
8/31/2024	145,315	-7,156	1,404	3,006	17
2/29/2024	144,597	-6,037	-1,766	101	N/A
11/30/2023	142,406	574	-529	1,484	N/A
8/31/2023	139,081	-3,080	141	2,258	N/A
5/31/2023	136,108	-3,315	-821	1,305	N/A
2/28/2023	133,291	-3,144	982	2,954	N/A
11/30/2022	132,184	-2,964	1,403	3,293	N/A
8/31/2022	132,703	4,337	2,165	3,899	N/A
5/31/2022	134,516	5,111	3,439	5,058	N/A
2/28/2022	135,948	5,926	3,626	5,183	N/A
11/30/2021	134,972	5,965	4,057	5,459	N/A
8/31/2021	132,509	1,994	4,176	5,555	N/A
5/31/2021	128,617	1,972	4,983	6,396	N/A
2/28/2021	124,952	-926	4,195	5,556	N/A
11/30/2020	123,509	-981	4,200	5,618	N/A
8/31/2020	121,982	179	4,110	5,484	N/A
5/31/2020	125,566	519	4,359	5,777	N/A
2/29/2020	129,792	3,339	5,269	6,883	N/A
11/30/2019	132,984	3,628	4,576	6,195	N/A
8/31/2019	120,074	3,816	3,892	5,594	N/A
5/31/2019	136,354	4,817	4,402	6,032	N/A
2/28/2019	136,097	5,133	4,756	6,250	N/A
11/30/2018	134,590	5,326	6,261	7,720	N/A
8/31/2018	131,537	5,024	6,896	8,263	N/A
5/31/2018	128,244	4,314	6,038	7,460	N/A
2/28/2018	124,028	4,134	5,699	7,077	N/A
11/30/2017	120,453	3,845	N/A	7,729	N/A
8/31/2017	118,214	4,078	N/A	7,255	N/A
5/31/2017	116,701	4,306	N/A	7,895	N/A
2/28/2017	116,081	4,247	N/A	8,144	N/A
11/30/2016	116,819	4,117	N/A	7,640	N/A
8/31/2016	117,351	4,173	N/A	7,847	N/A
5/31/2016	117,237	3,169	N/A	6,694	N/A
2/29/2016	116,534	3,368	N/A	6,412	N/A
11/30/2015	112,923	4,480	N/A	5,365	N/A
8/31/2015	103,444	4,220	N/A	5,664	N/A
5/31/2015	93,979	3,973	N/A	5,543	N/A
2/28/2015	84,585	3,385	N/A	4,993	N/A
11/30/2014	77,617	2,059	N/A	4,791	N/A
8/31/2014	76,392	1,932	N/A	3,893	N/A
5/31/2014	75,276	2,810	N/A	3,632	N/A
2/28/2014	74,188	2,720	N/A	3,739	N/A
11/30/2013	73,230	2,760	N/A	3,833	N/A
8/31/2013	72,217	2,548	N/A	4,301	N/A
5/31/2013	71,349	2,146	N/A	3,946	N/A

Previsiones de crecimiento futuro de los analistas

Ingresos vs. Tasa de ahorro: Se prevé que WBA sea rentable en los próximos 3 años, lo que se considera un crecimiento más rápido que la tasa de ahorro (2.3%).

Beneficios vs. Mercado: Se prevé que WBA sea rentable en los próximos 3 años, lo que se considera un crecimiento del mercado superior a la media.

Beneficios de alto crecimiento: Se espera que WBA sea rentable en los próximos 3 años.

Ingresos vs. Mercado: Se prevé que los ingresos (3.7% al año) de WBA crezcan más despacio que el mercado de US (8.1% al año).

Ingresos de alto crecimiento: Se prevé que los ingresos 3.7% al año) de WBA crezcan más despacio que 20% al año.

Previsiones de crecimiento de los beneficios por acción

Rentabilidad financiera futura

ROE futura: Se prevé que la rentabilidad financiera de WBA sea baja dentro de 3 años (19.4%).

Descubre empresas en crecimiento

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Price

Mkt cap

E.Growth

Analysts Target

Walgreens Boots Alliance Crecimiento futuro

Future controles de criterios 3/6

Información clave

Actualizaciones recientes sobre el crecimiento futuro

Consensus EPS estimates fall by 11%

Consensus EPS estimates increase by 11%

Consensus EPS estimates fall by 14%

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Price target decreased by 10.0% to US$27.77

Price target decreased by 9.5% to US$36.27

Recent updates

Second quarter dividend of US$0.25 announced

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on June 12, 2024

3 Reasons Walgreens Can See Upside (Rating Upgrade)

Investors Still Waiting For A Pull Back In Walgreens Boots Alliance, Inc. (NASDAQ:WBA)

Walgreens: New Management Team And Cost-Plus Model Are Exactly What The Doctor Prescribed

New major risk - Financial position

Consensus EPS estimates fall by 11%

Walgreens Earnings Preview: Revenue Estimates Holding Up; It's A Cost Structure Problem

Walgreens' Strategic Pivot

Consensus EPS estimates increase by 11%

Walgreens Q2, Dow Exit, And Bet Against Wall Street

Wisner Baum Files Multiple Class Actions Alleging Several Companies Sold Benzoyl Peroxide Acne Products Without Warning Consumers That They Contain Unsafe Levels of Benzene, a Potent Human Carcinogen

Walgreens Boots Alliance, Inc. to Report Q2, 2024 Results on Mar 28, 2024

Walgreens Boots Alliance, Inc. Names Lanesha Minnix as Executive Vice President and Global Chief Legal Officer

Consensus EPS estimates fall by 14%

Walgreens: New CEO Looking To Right The Ship

Walgreens Boots Alliance, Inc. Announces Executive Changes

Upcoming dividend of US$0.25 per share at 4.4% yield

High number of new directors

Walgreens Boots Alliance, Inc. Elects Robert L. Huffines to Board of Directors

Walgreens Reportedly Explores $4 Billion-Plus Sale of Shields Health

Walgreens Boots Alliance (NASDAQ:WBA) Use Of Debt Could Be Considered Risky

Walgreens Boots Alliance: Income Opportunity After Dividend Cut

Walgreens Q1: Dividend Cut Now What? (Rating Upgrade)

First quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on March 12, 2024

After Leaping 26% Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Are Not Flying Under The Radar

The Shareholder Commons, Inc Files a Notice of Exempt Solicitation to Walgreens Boots Alliance, Inc

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 25, 2024

Walgreens Boots Alliance, Inc. to Report Q1, 2024 Results on Jan 04, 2024

Upcoming dividend of US$0.48 per share at 8.7% yield

Walgreens Boots Alliance Names Neal Sample Executive Vice President and Chief Information Officer

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

Walgreens Boots Alliance, Inc. Declares Quarterly Dividend, Payable on December 12, 2023

Walgreens Boots Alliance, Inc. Provides Earnings Guidance for the Fiscal Year 2024

Full year 2023 earnings: EPS misses analyst expectations

Price target decreased by 10.0% to US$27.77

Walgreens Boots Alliance, Inc. Appoints Tim Wentworth as Chief Executive Officer, Effective October 23, 2023

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Walgreens Boots Alliance, Inc.(NasdaqGS:WBA) dropped from S&P 100

Dicello Levitt Files Lawsuit Against Kenvue, Procter & Gamble, Glaxosmithkline, and Walgreens

Walgreens Boots Alliance, Inc. Announces CEO Changes

Upcoming dividend of US$0.48 per share at 6.6% yield

High number of new directors

Walgreens Boots Alliance (NASDAQ:WBA) Will Pay A Dividend Of $0.48

Walgreens Boots Alliance, Inc. Announces Departure of James Kehoe as Executive Vice President

Walgreens Boots Alliance (NASDAQ:WBA) Has Announced A Dividend Of $0.48

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on September 12, 2023

Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) entered into an agreement to acquire 120 pharmacies in Texas, Louisiana and Arkansas from Brookshire Grocery Company.

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Price target decreased by 9.5% to US$36.27

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

An unknown buyer acquired 6.004471% stake in Option Care Health, Inc. (NasdaqGS:OPCH) from Walgreens Boots Alliance, Inc. (NasdaqGS:WBA) for approximately $330 million.

Walgreens Boots Alliance, Inc. to Report Q3, 2023 Results on Jun 27, 2023

Upcoming dividend of US$0.48 per share at 6.1% yield

Walgreens Boots Alliance's (NASDAQ:WBA) Dividend Will Be $0.48

CEO & Director recently bought US$340k worth of stock

Second quarter 2023 earnings: EPS and revenues exceed analyst expectations

Walgreens Boots Alliance (NASDAQ:WBA) Has A Somewhat Strained Balance Sheet

Consensus EPS estimates upgraded to US$1.84 loss

Upcoming dividend of US$0.48 per share at 5.2% yield

Walgreens Boots Alliance (NASDAQ:WBA) Has Affirmed Its Dividend Of $0.48

Walgreens Boots Alliance Declares Quarterly Dividend, Payable on March 10, 2023

Walgreens Reportedly Weighs $2 Billion Sale of Pharmacy Automation Unit

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Walgreens Boots Alliance, Inc. Provides Sales Guidance for Fiscal 2023

Walgreens Boots Alliance, Inc. to Report Q1, 2023 Results on Jan 05, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023

Walgreens Boots Alliance, Inc., Annual General Meeting, Jan 26, 2023